Foundation Fighting Blindness Retinal Degeneration Fund — SEC Form 4 filings

SEC reporting owner CIK 2042266. 3 Form 4 filings on record with FilingPulse; latest filed 2026-05-20.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-05-06 to 2026-05-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Opus Genetics, Inc. (IRD)Director32 legs · 5,700,000 sh · $15,995,0002

Form 4 filings — Foundation Fighting Blindness Retinal Degeneration Fund

FiledFormIssuerReported transactionsSource
2026-05-204Opus Genetics, Inc. (IRD)
jointly with Foundation Fighting Blindness, Inc.
Sale (S): 1,700,000 @ $4.35EDGAR
2025-12-114Opus Genetics, Inc. (IRD)
jointly with Foundation Fighting Blindness, Inc.
Sale (S): 4,000,000 @ $2.15EDGAR
2025-05-064Opus Genetics, Inc. (IRD)
jointly with Foundation Fighting Blindness, Inc.
Conversion (C): 6,927,419 · Conversion (C): 6,927.42 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2042266 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →